Acute oral trimetazidine administration increases resting technetium 99m sestamibi uptake in hibernating myocardium.

Ciavolella, M; Greco, C; Tavolaro, R; Tanzilli, G; Scopinaro, F; Campa, P P

Ciavolella, M; Greco, C; Tavolaro, R; Tanzilli, G; Scopinaro, F; Campa, P P.

Affiliation

Ciavolella M; 2nd Department of Cardiology and the Institute of Nuclear Medicine, University La Sapienza, Rome, Italy.

J Nucl Cardiol ; 5(2): 128-33, 1998.

Article in En | MEDLINE | ID: mdl-9588664

Subject(s)

Myocardial Stunning/diagnostic imaging; Technetium Tc 99m Sestamibi; Trimetazidine/administration & dosage; Vasodilator Agents/administration & dosage; Administration, Oral; Coronary Circulation; Echocardiography; Heart/diagnostic imaging; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction/diagnostic imaging; Myocardial Infarction/physiopathology; Myocardial Infarction/surgery; Myocardial Revascularization; Myocardial Stunning/drug therapy; Myocardial Stunning/physiopathology; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals/pharmacokinetics; Technetium Tc 99m Sestamibi/pharmacokinetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Trimetazidine / Vasodilator Agents / Technetium Tc 99m Sestamibi / Myocardial Stunning Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: J Nucl Cardiol Journal subject: CARDIOLOGIA Year: 1998 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links